Blue Ridge Capital’s Endo International plc ENDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-2,050,000
Closed -$126M 56
2015
Q4
$126M Sell
2,050,000
-2,150,000
-51% -$131M 1.4% 34
2015
Q3
$291M Hold
4,200,000
3.35% 8
2015
Q2
$335M Sell
4,200,000
-739,000
-15% -$63.8M 3.77% 5
2015
Q1
$443M Buy
4,939,000
+530,000
+12% +$44.3M 5.05% 2
2014
Q4
$318M Sell
4,409,000
-1,289,528
-23% -$88.3M 3.86% 6
2014
Q3
$389M Sell
5,698,528
-1,116,472
-16% -$73.5M 4.61% 3
2014
Q2
$477K Sell
6,815,000
-1,185,000
-15% -$79.2M 4.71% 2
2014
Q1
$549M Hold
8,000,000
6.07% 1
2013
Q4
$540M Buy
8,000,000
+1,000,000
+14% +$57.1M 5.56% 1
2013
Q3
$318M Buy
7,000,000
+200,000
+3% +$8.04M 3.8% 6
2013
Q2
$250M Buy
+6,800,000
New +$244M 3.02% 10

Other funds holding ENDP

Blue Ridge Capital's ENDP Position: Q1 2016 in Review

Blue Ridge Capital sold out of Endo International plc (ENDP) in Q1 2016, closing a stake of 2,050,000 shares — an estimated $126M sold.

Blue Ridge Capital first reported a position in ENDP in Q2 2013 and held it in 11 quarters. The position peaked at $549M in Q1 2014. 342 funds tracked by Wall St. Rank hold ENDP as of Q1 2016.

  • Blue Ridge Capital reported no remaining Endo International plc position as of Q1 2016 after selling out during the quarter.
  • Blue Ridge Capital sold 2,050,000 Endo International plc shares in Q1 2016, an estimated $126M.
  • Blue Ridge Capital first reported a position in Endo International plc in Q2 2013 and held it in 11 quarters.
  • Blue Ridge Capital's Endo International plc position peaked at $549M in Q1 2014.
  • 342 funds tracked by Wall St. Rank held Endo International plc as of Q1 2016.

Based on Blue Ridge Capital's 13F filing for Q1 2016, filed 16 May 2016.